VSC — 4Sc AG Share Price
Last Trade - 00:00- €57.85m
- €23.21m
- €2.25m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 2.06 | 4.2 | 4.17 | 2.2 | 2.25 | 1 | 21 | -0.39% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
4Sc AG is a Germany-based clinical-stage biopharmaceutical company that develops small-molecule drugs that target key indications in cancer through epigenetic mechanisms. The Company’s product pipeline includes several anti-cancer drugs, which are in various stages of preclinical and clinical development. Its main products are Resminostat, an orally administered histone deacetylase (HDAC) inhibitor for the treatment of a broad spectrum of oncology indications, both in monotherapy in combination with other anti-cancer drugs; 4SC-202, an orally administered small molecule and epigenetic modulator that inhibits the enzymes lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) 1, 2, 3, and 4SC-208, a small molecule that targets two kinases for Hedgehog/GLI signaling.
Directors
- Clemens Doppler CSU (62)
- Jason Loveridge CMG
- Joerg von Petrikowsky VSU (61)
- Susanne Danhauser-Riedl
- Frank Hermann
- Irina Antonijevic (54)
- Helmut Jeggle (49)
- Helga Ruebsamen-Schaeff (72)
- Manfred Ruediger SUB (55)
- Last Annual
- December 31st, 2020
- Last Interim
- December 31st, 2020
- Incorporated
- January 1st, 1970
- Public Since
- February 25th, 2008
- No. of Employees
- 43
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- XETRA
- Shares in Issue
- 10,114,009
- Address
- Fraunhoferstr. 22, PLANEGG, 82152
- Web
- https://www.4sc.de
- Phone
- +49 897007630
- Contact
- Anna Niedl
- Auditors
- Baker Tilly Gmbh & Co. KG
Latest News for VSC
Upcoming events for VSC
Q3 2021 4Sc AG Earnings Release
Similar to VSC
FAQ
As of Today at 11:30 UTC, shares in 4Sc AG are trading at €5.72. This share price information is delayed by 15 minutes.
Shares in 4Sc AG last closed at €5.72 and the price had moved by +216.9% over the past 365 days. In terms of relative price strength the 4Sc AG share price has outperformed the FTSE Global All Cap Index by +147.73% over the past year.
The overall consensus recommendation for 4Sc AG is Buy. You can view the full broker recommendation list by unlocking its StockReport.
4Sc AG does not currently pay a dividend.
4Sc AG does not currently pay a dividend.
4Sc AG does not currently pay a dividend.
To buy shares in 4Sc AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €5.72, shares in 4Sc AG had a market capitalisation of €57.85m.
Here are the trading details for 4Sc AG:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: VSC
Based on an overall assessment of its quality, value and momentum 4Sc AG is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in 4Sc AG is €23.70. That is 314.34% above the last closing price of €5.72.
Analysts covering 4Sc AG currently have a consensus Earnings Per Share (EPS) forecast of -€2.72 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like 4Sc AG. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +146.74%.
As of the last closing price of €5.72, shares in 4Sc AG were trading +159.14% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for 4Sc AG.
4Sc AG's management team is headed by:
- Clemens Doppler - CSU
- Jason Loveridge - CMG
- Joerg von Petrikowsky - VSU
- Susanne Danhauser-Riedl -
- Frank Hermann -
- Irina Antonijevic -
- Helmut Jeggle -
- Helga Ruebsamen-Schaeff -
- Manfred Ruediger - SUB
We do not have data on 4Sc AG's shareholders